The homozygous deletion resulting in functional loss of the GSTM1 enzyme has been implicated in the genesis of several cancers, including cervical neoplasia [15], colorectal cancer [34] and bladder cancer [35]. This evidence concerns the gene GSTM1 and urinary bladder cancer.